A chitosan lactate/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: Design and in vitro evaluation

Drug Development and Industrial Pharmacy

Volumn 39, Issue 12, 2013, Pages 1911-1920

  Parodi, Brunella ^a   Russo, Eleonora ^a   Caviglioli, Gabriele ^a   Baldassari, Sara ^a   Gaglianone, Noemi ^a   Schito, Anna Maria ^a   Cafaggi, Sergio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Controlled release; Delivery system; Econazole; Eudragit RS 100; Microparticles; Mucoadhesion; Poloxamer 407

Indexed keywords

ECONAZOLE; EUDRAGIT RS; LACTIC ACID; POLOXAMER;

ARTICLE; CANDIDA ALBICANS; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; ENTHALPY; IN VITRO STUDY; MUCOADHESION; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SWELLING;

ACRYLIC RESINS; ADHESIVENESS; ADMINISTRATION, INTRAVAGINAL; ANTIFUNGAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CANDIDA ALBICANS; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ECONAZOLE; EMULSIONS; LACTIC ACID; MICROSPHERES; POLOXAMER; TIME FACTORS;

EID: 84887254853     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.694589     Document Type: Article

References (41)

1. Sobel JD. (2007). Vulvovaginal candidosis. Lancet, 369:1961-1971. (Pubitemid 46874580)
2. das Neves J, Pinto E, Teixeira B, Dias G, Rocha P, Cunha T et al. (2008). Local treatment of vulvovaginal candidosis: general and practical considerations. Drugs, 68:1787-1802.
3. Valenta C. (2005). The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev, 57:1692-1712. (Pubitemid 41444256)
4. Brown J, Hooper G, Kenyon CJ, Haines S, Burt J, Humphries JM et al. (1997). Spreading and retention of vaginal formulations in postmenopausal women as assessed by gamma scintigraphy. Pharm Res, 14:1073-1078. (Pubitemid 27371409)
5. Kast CE, Valenta C, Leopold M, Bernkop-Schnürch A. (2002). Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J Control Release, 81:347-354. (Pubitemid 34607154)
6. Yoo JW, Dharmala K, Lee CH. (2006). The physicodynamic properties of mucoadhesive polymeric films developed as female controlled drug delivery system. Int J Pharm, 309:139-145. (Pubitemid 43129476)
7. Bouckaert S, Temmerman M, Voorspoels J, Van Kets H, Remon JP, Dhont M. (1995). Preliminary efficacy study of a bioadhesive vaginal metronidazole tablet in the treatment of bacterial vaginosis. J Pharm Pharmacol, 47:970-971. (Pubitemid 26020158)
8. Chang JY, Oh YK, Kong HS, Kim EJ, Jang DD, Nam KT et al. (2002). Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release, 82:39-50.
9. Ning MY, Guo YZ, Pan HZ, Chen XL, Gu ZW. Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Dev Ind Pharm. 2005;31:375-383.
10. Pavelic Z, Skalko-Basnet N, Filipovic-Grcic J, Martinac A, Jalsenjak I. (2005). Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J Control Release, 106:34-43. (Pubitemid 41140079)
11. Thirawong N, Thongborisute J, Takeuchi H, Sriamornsak P. (2008). Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes. J Control Release, 125:236-245.
12. O'Hagan DT, Rafferty D, Wharton S, Illum L. (1993). Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system. Vaccine, 11:660-664. (Pubitemid 23142624)
13. Hunter SK, Andracki ME, Krieg AM. (2001). Biodegradable microspheres containing group B Streptococcus vaccine: immune response in mice. Am J Obstet Gynecol, 185:1174-1179. (Pubitemid 33097383)
14. Karn PR, Vanic Z, Pepic I, Skalko-Basnet N. (2011). Mucoadhesive liposomal delivery systems: the choice of coating material. Drug Dev Ind Pharm, 37:482-488.
15. Gavini E, Sanna V, Juliano C, Bonferoni MC, Giunchedi P. (2002). Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine. AAPS PharmSciTech, 3:E20.
16. Albertini B, Passerini N, Di Sabatino M, Vitali B, Brigidi P, Rodriguez L. (2009). Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate. Eur J Pharm Sci, 36:591-601.
17. Kumar M. A review of chitin and chitosan applications. React Funct Polym. 2000;46:1-27. (Pubitemid 33763425)
18. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. (2004). Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release, 100:5-28. (Pubitemid 39445982)
19. Perioli L, Ambrogi V, Venezia L, Pagano C, Ricci M, Rossi C. (2008). Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels. Colloids Surf B Biointerfaces, 66:141-145.
20. Cafaggi S, Leardi R, Parodi B, Caviglioli G, Russo E, Bignardi G. (2005). Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery. J Control Release, 102:159-169. (Pubitemid 40093782)
21. Desai SD, Blanchard J. (1998). In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine. J Pharm Sci, 87:226-230. (Pubitemid 28081333)
22. Czeizel AE, Kazy Z, Vargha P. (2003). A population-based case-control teratological study of vaginal econazole treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol, 111:135-140. (Pubitemid 37338730)
23. Adibkia K, Javadzadeh Y, Dastmalchi S, Mohammadi G, Niri FK, Alaei-Beirami M. (2011). Naproxen-eudragit RS100 nanoparticles: preparation and physicochemical characterization. Colloids Surf B Biointerfaces, 83:155-159.
24. Fujimori J, Yoshihashi Y, Yonemochi E, Terada K. (2005). Application of Eudragit RS to thermo-sensitive drug delivery systems: II. Effect of temperature on drug permeability through membrane consisting of Eudragit RS/PEG 400 blend polymers. J Control Release, 102:49-57. (Pubitemid 40093775)
25. Haznedar S, Dortunç B. (2004). Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm, 269:131-140. (Pubitemid 38032830)
26. Kramar A, Turk S, Vrecer F. (2003). Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films. Int J Pharm, 256:43-52. (Pubitemid 36412138)
27. González-Rodríguez ML, Maestrelli F, Mura P, Rabasco AM. (2003). In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery. Eur J Pharm Sci, 20:125-131. (Pubitemid 37103240)
28. Narisawa S, Nagata M, Hirakawa Y, Kobayashi M, Yoshino H. (1996). An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid. J Pharm Sci, 85:184-188.
29. Maghsoodi M, Sadeghpoor F. (2010). Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique. Drug Dev Ind Pharm, 36:917-925.
30. Korsmeyer R, Gurny R, Doelker E, Buri P, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25-35. (Pubitemid 13092121)
31. Parodi B, Russo E, Gatti P, Cafaggi S, Bignardi G. (1999). Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane. Drug Dev Ind Pharm, 25:289-295. (Pubitemid 29108675)
32. Tao YY, Lu YF, Sun YJ, Gu B, Lu WY, Pan J. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability. Int J Pharm. 2009;378:30-36.
33. Alhnan MA, Basit AW. (2011). In-process crystallization of acidic drugs in acrylic microparticle systems: influence of physical factors and drug-polymer interactions. J Pharm Sci, 100:3284-3293.
34. Hombreiro-Pérez M, Siepmann J, Zinutti C, Lamprecht A, Ubrich N, Hoffman M et al. (2003). Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling. J Control Release, 88:413-428. (Pubitemid 36331883)
35. Huang J, Wigent RJ, Schwartz JB. (2008). Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend. J Pharm Sci, 97:251-262.
36. Dvorácková K, Rabisková M, Masteiková R, Muselík J, Krejcová K. (2009). Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets. Drug Dev Ind Pharm, 35:930-940.
37. Efentakis M, Buckton G. (2002). The effect of erosion and swelling on the dissolution of theophylline from low and high viscosity sodium alginate matrices. Pharm Dev Technol, 7:69-77. (Pubitemid 35154416)
38. Rokhade AP, Shelke NB, Patil SA, Aminabhavi TM. (2007). Novel hydrogel microspheres of chitosan and pluronic F-127 for controlled release of 5-fluorouracil. J Microencapsul, 24:274-288.
39. Angadi SC, Manjeshwar LS, Aminabhavi TM. Stearic acid-coated chitosan-based interpenetrating polymer network microspheres: Controlled release characteristics. Indust Engg Chemistry Res. 2011;50:4504-4514.
40. Agnihotri SA, Aminabhavi TM. (2007). Chitosan nanoparticles for prolonged delivery of timolol maleate. Drug Dev Ind Pharm, 33:1254-1262. (Pubitemid 350208731)
41. Liu YH, Zhu X, Zhou D, Jin Y, Zhao CY, Zhang ZR et al. (2011). pH-sensitive and mucoadhesive microspheres for duodenumspecific drug delivery system. Drug Dev Ind Pharm, 37:868-874.